HeartSciences Inc Warrant
HSCSW
5 hedge funds and large institutions have $21.8K invested in HeartSciences Inc Warrant in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.21% less ownership
Funds ownership: 1.04% → 0.83% (-0.21%)
35% less capital invested
Capital invested by funds: $33.3K → $21.8K (-$11.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.17K |
| 3 |
CS
Clear Street
New York
|
+$137 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$130 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$17.6K |
| 2 |
VF
Virtu Financial
New York
|
-$1K |
HSCSW Hedge Fund Activity: Q2 2024 in Review
5 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q2 2024, worth a combined $21.8K — down 35% from $33.3K a quarter earlier.
Fund positioning in HSCSW was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $7.4K. The largest seller was Armistice Capital, exiting entirely with an estimated $17.6K sold.
- 5 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $21.8K of HeartSciences Inc Warrant stock for Q2 2024, down 35% quarter-over-quarter.
- 2 funds opened new HeartSciences Inc Warrant positions in Q2 2024 and 2 closed out, a net change of 0 holders.
- The largest HeartSciences Inc Warrant buyer in Q2 2024 was Citadel Advisors, an estimated $7.4K added.
- The largest HeartSciences Inc Warrant seller in Q2 2024 was Armistice Capital, an estimated $17.6K sold.
Based on aggregated 13F filings for Q2 2024.